about
Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine.Roles of p75(NTR), long-term depression, and cholinergic transmission in anxiety and acute stress copingAge-associated learning and memory deficits in two mouse versions of the Stone T-maze.The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expressionAlzheimer's disease drug development in 2008 and beyond: problems and opportunitiesImmobilized butyrylcholinesterase in the characterization of new inhibitors that could ease Alzheimer's diseaseCholinesterase inhibitors improve both memory and complex learning in aged beagle dogs.Resurrecting clinical pharmacology as a context for Alzheimer disease drug development.Phenserine efficacy in Alzheimer's disease.Emerging cognitive enhancing drugs.Dual inhibition: a novel promising pharmacological approach for different disease conditions.In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.Old and new acetylcholinesterase inhibitors for Alzheimer's disease.Progress in the development of new drugs in Alzheimer's disease.The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials.Pharmacophore-based design and discovery of (-)-meptazinol carbamates as dual modulators of cholinesterase and amyloidogenesis.Determination of Meserine, a new candidate for Alzheimer's disease in mice brain by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic and tissue distribution study.
P2860
Q34338594-E55C154A-B3AC-4B60-9539-E84ED10CDC3FQ35592894-7D33B4CC-7169-4FC5-B977-619C79CA4321Q35875514-88AAEBA3-B425-4ECA-82D5-6B0A7239575EQ36012226-69B279FA-6F11-4F7E-9F9D-6D916C0FB154Q36942970-DF1A84B1-80DB-4543-A1AB-77245EAE683EQ37122955-1FAF71F5-EDC1-48FC-9261-303DE2F65CAEQ37163279-ADAEAA3C-7F94-4A56-A365-156B48EC6999Q37387281-FDEE3459-D7AA-4012-85DF-B57EA0E88DBEQ37510264-1126D7D9-8098-40A4-BB1C-E161199E4F7EQ37601479-DBB3B1AC-E9C6-437D-9713-F0FF928179A8Q37852762-CAE5ABFE-FD46-44C8-A15B-0B33D815A0B9Q37870701-B324E05F-6792-41AE-A9C7-0BC9B98F7EC8Q38099889-96639734-3BC8-4439-B445-19ACD4072F41Q38908823-DBFA9EF2-C916-4DDD-A704-86658154B91CQ39789745-4DD630C8-1627-4790-9FC7-608DFEC3AD54Q47127039-BBF8A013-9335-43A4-B153-6F84D36F7B85Q50678690-56AF6517-CF28-4C17-AAA4-3E20F04ECDE3Q53351906-D02A8255-5EF3-4C05-80DF-68FCDA2925BD
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Phenserine.
@en
type
label
Phenserine.
@en
prefLabel
Phenserine.
@en
P2860
P1476
Phenserine.
@en
P2860
P304
P356
10.1517/13543784.16.7.1087
P407
P50
P577
2007-07-01T00:00:00Z